T. Rowe Price Investment Management, Inc.
Position in IRMD — Iradimed Corp
CIK 1897612
BALTIMORE, MD
Position in IRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,709,653
-$183,034 QoQ
Shares Held
256,697
+0.3% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRMD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $1,106,407,711 across 15 Medical Devices names. IRMD ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,815,742 | $381,015,301 | |
| 2 | ABT |
Abbott Laboratories
|
2,764,429 | $283,823,925 | |
| 3 | NEOG |
Neogen Corp
|
10,162,715 | $94,411,622 | |
| 4 | QDEL |
QuidelOrtho Corp
|
5,629,965 | $92,500,324 | |
| 5 | PRCT |
PROCEPT BioRobotics Corp
|
3,273,794 | $81,877,587 | |
| 6 | AVNS |
Avanos Medical, Inc.
|
5,330,776 | $74,684,171 | |
| 7 | HAE |
Haemonetics Corp
|
597,155 | $33,655,655 | |
| 8 | IRMD |
Iradimed Corp
This page
|
256,697 | $24,709,653 |
All Filings in IRMD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,709,653 | 256,697 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,892,687 | 255,887 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $3,565,400 | 50,104 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||